| # | Title | Journal | Year | Citations |
|---|
| 1 | Intra-arterial Prourokinase for Acute Ischemic Stroke | JAMA - Journal of the American Medical Association | 1999 | 2,784 |
| 2 | A clinical approach to diagnosis of autoimmune encephalitis | Lancet Neurology, The | 2016 | 2,782 |
| 3 | Three or more routes for leukocyte migration into the central nervous system | Nature Reviews Immunology | 2003 | 934 |
| 4 | Use of the brain parenchymal fraction to measure whole brain atrophy in relapsing-remitting MS | Neurology | 1999 | 688 |
| 5 | Proposal for a New Classification of Outcome with Respect to Epileptic Seizures Following Epilepsy Surgery | Epilepsia | 2003 | 665 |
| 6 | Gene delivery of AAV2-neurturin for Parkinson's disease: a double-blind, randomised, controlled trial | Lancet Neurology, The | 2010 | 589 |
| 7 | Functional connectivity in the human language system: a cortico-cortical evoked potential study | Brain | 2004 | 569 |
| 8 | Genome-wide Analyses Identify KIF5A as a Novel ALS Gene | Neuron | 2018 | 517 |
| 9 | Calcium-sensitive potassium channelopathy in human epilepsy and paroxysmal movement disorder | Nature Genetics | 2005 | 513 |
| 10 | Dose Escalation of Desmoteplase for Acute Ischemic Stroke (DEDAS) | Stroke | 2006 | 511 |
| 11 | Seizure outcome after epilepsy surgery in children and adolescents | Annals of Neurology | 1998 | 482 |
| 12 | MOVEMENT-RELATED POTENTIALS RECORDED FROM SUPPLEMENTARY MOTOR AREA AND PRIMARY MOTOR AREA | Brain | 1992 | 421 |
| 13 | The measurement and clinical relevance of brain atrophy in multiple sclerosis | Lancet Neurology, The | 2006 | 406 |
| 14 | Arrest of motor neuron disease in wobbler mice cotreated with CNTF and BDNF | Science | 1994 | 403 |
| 15 | Mutations in the Matrin 3 gene cause familial amyotrophic lateral sclerosis | Nature Neuroscience | 2014 | 398 |
| 16 | Benefit of interferon β-1a on MSFC progression in secondary progressive MS | Neurology | 2002 | 391 |
| 17 | Surgical outcome and prognostic factors of frontal lobe epilepsy surgery | Brain | 2007 | 377 |
| 18 | BASAL TEMPORAL LANGUAGE AREA | Brain | 1991 | 370 |
| 19 | Cooling for Acute Ischemic Brain Damage (COOL AID) | Neurology | 2004 | 368 |
| 20 | Functional anatomy of the human supplementary sensorimotor area: results of extraoperative electrical stimulation | Electroencephalography and Clinical Neurophysiology | 1994 | 337 |
| 21 | Association of Traumatic Brain Injury With Late-Life Neurodegenerative Conditions and Neuropathologic Findings | JAMA Neurology | 2016 | 337 |
| 22 | Dextromethorphan Plus Ultra Low‐Dose Quinidine Reduces Pseudobulbar Affect | Annals of Neurology | 2010 | 324 |
| 23 | Hemicraniectomy for Massive Middle Cerebral Artery Territory Infarction | Stroke | 2004 | 323 |
| 24 | Poly(ADP-ribose) drives pathologic α-synuclein neurodegeneration in Parkinson’s disease | Science | 2018 | 317 |
| 25 | Intracranial hemorrhage and hyperperfusion syndrome following carotid artery stenting | Journal of the American College of Cardiology | 2004 | 313 |
| 26 | A Randomized Clinical Trial of High-Dosage Coenzyme Q10 in Early Parkinson Disease | JAMA Neurology | 2014 | 312 |
| 27 | West Nile virus infection | Neurology | 2003 | 296 |
| 28 | Predictors of neurologic outcome in hypothermia after cardiac arrest | Annals of Neurology | 2010 | 291 |
| 29 | Functional connectivity in human cortical motor system: a cortico-cortical evoked potential study | Brain | 2006 | 271 |
| 30 | Utilization of Intravenous Tissue Plasminogen Activator for Acute Ischemic Stroke | Archives of Neurology | 2004 | 259 |
| 31 | Deep Brain Stimulation in Epilepsy | Journal of Clinical Neurophysiology | 2001 | 255 |
| 32 | Hemodynamic correlates of epileptiform discharges: An EEG-fMRI study of 63 patients with focal epilepsy | Brain Research | 2006 | 255 |
| 33 | Challenges With the Diagnosis and Treatment of Cerebral Radiation Necrosis | International Journal of Radiation Oncology Biology Physics | 2013 | 251 |
| 34 | Empirical methods for assessing meaningful neuropsychological change following epilepsy surgery | Journal of the International Neuropsychological Society | 1996 | 242 |
| 35 | Mechanisms of deep brain stimulation and future technical developments | Neurological Research | 2000 | 242 |
| 36 | Patient selection and assessment recommendations for deep brain stimulation in Tourette syndrome | Movement Disorders | 2006 | 238 |
| 37 | Validity of performance scales for disability assessment in multiple sclerosis | Multiple Sclerosis Journal | 2007 | 237 |
| 38 | Sixteen novel mutations in the Cu/Zn superoxide dismutase gene in amyotrophic lateral sclerosis: a decade of discoveries, defects and disputes | Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders: Official Publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases | 2003 | 234 |
| 39 | The spectrum of neurologic disease associated with anti‐GM 1 antibodies | Neurology | 1990 | 233 |
| 40 | Serotonin syndrome | Neurology | 1995 | 232 |
| 41 | The localizing value of ictal EEG in focal epilepsy | Neurology | 2001 | 229 |
| 42 | Impact of interferon beta-1a on neurologic disability in relapsing multiple sclerosis | Neurology | 1997 | 225 |
| 43 | Chemokines and chemokine receptors in inflammation of the nervous system: manifold roles and exquisite regulation | Immunological Reviews | 2000 | 224 |
| 44 | “TScores for Change”: An illustration of a regression approach to depicting change in clinical neuropsychology | Neuropsychology, Development and Cognition Section D: the Clinical Neuropsychologist | 1993 | 223 |
| 45 | Predictors of outcome after temporal lobectomy for the treatment of intractable epilepsy | Neurology | 2006 | 220 |
| 46 | The interferons: Biological effects, mechanisms of action, and use in multiple sclerosis | Annals of Neurology | 1995 | 214 |
| 47 | Epilepsy Surgery in Infants | Epilepsia | 1996 | 214 |
| 48 | In vivo effects of interferon beta-1a on immunosuppressive cytokines in multiple sclerosis | Neurology | 1998 | 213 |
| 49 | Quality of Life in Multiple Sclerosis | Archives of Neurology | 1992 | 211 |
| 50 | Phase II trial of CoQ10 for ALS finds insufficient evidence to justify phase III | Annals of Neurology | 2009 | 211 |
